Highlights
NASDAQ: IFRX       Fireman B.V.
Last Price Today's Change   Day's Range   Trading Volume
1.52   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):75,867
4 Weeks Range:1.12 - 1.62
4 Weeks Price Volatility (%):
93.83%
52 Weeks Range:1.12 - 5.686
52 Weeks Price Volatility (%):
26.73%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

InflaRx NV is a clinical-stage biopharmaceutical company is focused on applying proprietary anti-C5a technology to discover and develop specific inhibitors of the complement activation factor known as C5a. The lead product candidate of the company is IFX-1, which is developed for the treatment of Hidradenitis Suppurativa, a rare and chronic debilitating systemic inflammatory skin disease. The company's proprietary anti-C5a technology is an inflammatory mediator involved in the progression of a variety of autoimmune and other inflammatory diseases. It is also developing IFX-1 for the treatment of AAV, a life-threatening autoimmune disease associated with powerful inflammatory flares that impair kidney function and lead to fatal organ dysfunction.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

12303 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 DIG 33.190.00 
 DBS 28.4170.00 
 DUG 20.080.00 
 DTH 35.120.00 
 DTD 58.400.00 
 DSI 72.650.00 
 DRV 49.400.00 
 DRN 14.720.00 
 DON 39.670.00 
 DOL 42.340.00